COVID-19 treatments raked in billions of dollars in 2021. How will they do this year?

Four drug makers brought in more than $14 billion in sales of COVID-19 treatments in 2021, but the lucrative, new market could be tempered in 2022.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.